After completing his training in ophthalmology at the Casey Eye Institute in 2000, Dr. Suhler received an additional two years of training in uveitis clinical care and research at the National Eye Institute of the National Institutes of Health in Bethesda, Maryland from 2000 to 2002, and completed a Masters in Public Health from OHSU in 2007. 

He is Division Head of the OHSU Uveitis Clinic, where he sees patients on referral from eye care providers throughout the Pacific Northwest. He is active in clinical research and clinical trials utilizing cutting edge immunotherapeutic drugs for the treatment of ocular inflammatory diseases and has regularly presented the results of these trials at national and international research meetings. Dr. Suhler also directs the Casey Uveitis Fellowship. 

Dr. Suhler is also chief of ophthalmology at the Portland Veterans Administration Medical Center. He received his undergraduate education at Southern Methodist University in Dallas, Texas, and attended medical school at the University of Texas Southwestern Medical Center in Dallas. 

Financial disclosure: Dr. Suhler has/had an affiliation (financial or otherwise) with a commercial organization.

1. Roche/Genentech
2. Priovant
3. Gilead
4. EyePoint
5. Merck
6. Alumis
7. Kriya
8. Regeneron